Opportunities in Synthetic Biology
Les Tillack, CEO of Luina Bio, discusses how ‘synbio’ is driving growth in the biopharma industry.
Bioassay Development
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Bioanalytical Services | Bioassay Development | Breaking News | Facilities | Industry News
Ilya Pharma Acquires Nordic Bioanalysis
Site is located at the previous Astra Zeneca site in Södertälje, south of Stockholm.04.21.22
-
Bioassay Development | Breaking News | Industry News
Toxys Opens NY Sales Office and Facility in Maryland
Expansion in the U.S. supports the company’s growth strategy.03.16.22
-
Bio News | Bioassay Development | Breaking News | Collaborations & Alliances | Industry News
Promega and Fujifilm Cellular Dynamics Enter Assay Development Partnership
New licensing agreement will deliver luminescent reporter technology into iPSCs.03.10.22
-
Analytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Drug Development
Host Cell Impurities, Bioassays, Micro-Flow Imaging
WHO, FDA and the European Pharmacopoeia have established strict regulatory guidelines to guarantee product quality in biologics.
-
Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines
The Future of Continuous Bioprocessing
The modernization of advanced therapy manufacturing.Dr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 06.02.21
-
Bio News | Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Collaboration Creates Bio Hub in Northern UK
CDMO Fujifilm Diosynth Biotechnologies is part of Northern Bio-Accelerator Partnership.Contract Pharma Staff 12.16.20
-
Bioassay Development | Biologics, Proteins, Vaccines | Drug Development | Facilities
-
Bioassay Development | Breaking News | Industry News
GenScript Gets EUA for SARS-CoV-2 Neutralizing Antibody Detection Kit
cPass SARS-CoV-2 Neutralization Antibody kit is the only EUA authorized virus-free testing assay that detects neutralizing antibodies within an hour.Contract Pharma Staff 11.10.20
-
Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Process Development | Process Validation
eBook: Increase Time to Market with Precision Dispensing Technology
Discover how to make safe, productive, efficient bioprocessing a reality by exploring the benefits of precision dispensing technology.
-
Bio News | Bioassay Development | Breaking News | Collaborations & Alliances | CRO News | Industry News
Reaction Biology and 4HF Biotec Collaborate
Announce new cell-based service offering that combines their technologies.Contract Pharma Staff 10.21.20
-
Bio News | Bioanalytical Services | Bioassay Development | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Axxam and Fujifilm Cellular Dynamics Enter Alliance
Partner to deliver integrated hiPSC drug discovery solutions.Contract Pharma Staff 10.08.20
-
Bioassay Development | Drug Development | Drug Discovery
Technology Selection for Bioavailability Enhancement
Selection of the proper technology can make the difference between development success or failure. Learn more in this whitepaper from Lonza Pharma & Biotech.
-
Bio News | Bioassay Development | Breaking News | Industry News
Adma Biologics Launches COVID-19 Assay
Detects SARS-CoV-2 neutralizing antibodies in plasma.Contract Pharma Staff 09.03.20
-
Bioassay Development | Breaking News | Clinical Trials
Thermo Fisher Scientific Signs CDx Agreement with Hengrui Therapeutics
Will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib.Contract Pharma Staff 08.17.20
-
Bioassay Development | Breaking News | Collaborations & Alliances | Scale-up/Technology Transfer
Avacta Partners with BBI Solutions
BBI will manufacture the rapid SARS-CoV-2 antigen test that is being developed.Contract Pharma Staff 08.07.20
-
Bioassay Development
QPS Announces COVID-19 Testing Capability
Developed a QPCR assay to identify active novel coronavirus infections.Contract Pharma Staff 05.13.20
-
Bioassay Development | Breaking News | Industry News
Eurofins Genomics Launches SARS-CoV-2 Plasmid DNA Controls
Can be used to detect the presence of SARS-CoV-2 virus and are intended for both R&D and diagnostic applications.Contract Pharma Staff 04.16.20
-
Bioassay Development | Breaking News | Industry News | Laboratory Testing
COVID-19 Update: FDA Issues EUA to Hologic and LabCorp
More than 90 test developers have sought FDA guidance for tests they plan to offer through the EUA process03.18.20
-
Bioassay Development | Breaking News | CRO News | Industry News
Eurofins Grants Bioassay Certification to VelaLabs
Enables VelaLabs to perform highly reproducible potency lot release assays under GLP/GMP conditions02.24.20
-
Bio News | Bioassay Development | Biologics, Proteins, Vaccines | Breaking News | Industry News
GenScript Launches Coronavirus Detection Assay
Enables development of reliable molecular diagnostics for faster treatments and vaccines02.04.20
